Skip to main content

Table 1 Normalized steady-state mRNA expression levels (AU) of the CXCL2, PMAIP1 and MMD gene in monocytes of human volunteers before (T 0 ) and after (T 14 ) supplementation with ubiquinol

From: Ubiquinol decreases monocytic expression and DNA methylation of the pro-inflammatory chemokine ligand 2 gene in humans

Gene

T0

T14

Fold change

   

(T0 vs. T14)

PMAIP1

1271 ± 35

578 ± 106

-2,2

MMD

147 ± 30

85 ± 19

-1,7

CXCL2

1150 ± 865

93 ± 30

-12,4

  1. T0, expression levels before supplementation (baseline); T14, expression levels after a 14 day supplementation period with 150 mg/ d ubiquinol; fold change, relative change from time point T0 to T14; AU, arbitrary units; Data are given as mean ± SEM.